Teva Pharmaceutical Industries Ltd
TEVA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818686
In the last 90 days, Teva Pharmaceutical Industries Ltd insiders filed 0 open-market purchases and 8 sales; 675 institutions reported holding it in 13F filings for Q2 2026, worth $24.7B in total; 3 superinvestors hold it, including Greenlight Capital and Duquesne Family Office.
13F holders, Q1 2024
Institutional positions in Teva Pharmaceutical Industries Ltd as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 480
- +38 vs. Q4 2023
- Shares held
- 570.8M
- −6.50M (−1.1%) vs. Q4 2023
- Total value
- $8.05B
- +$1.98B (+32.6%) vs. Q4 2023
- New holders
- 71
- 177 more added
- Sold out
- 33
- 132 more reduced
5 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TEVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 675 | $24.7B |
| Q1 2026 | 654 | $20.1B |
| Q4 2025 | 632 | $21.4B |
| Q3 2025 | 552 | $13.3B |
| Q2 2025 | 541 | $11.9B |
| Q1 2025 | 561 | $11.0B |
| Q4 2024 | 584 | $14.7B |
| Q3 2024 | 544 | $11.3B |
| Q2 2024 | 534 | $9.88B |
| Q1 2024 | 480 | $8.05B |
| Q4 2023 | 447 | $6.07B |
| Q3 2023 | 435 | $5.66B |
| Q2 2023 | 428 | $3.76B |
| Q1 2023 | 438 | $4.95B |
| Q4 2022 | 422 | $5.08B |
| Q3 2022 | 430 | $4.51B |
| Q2 2022 | 457 | $3.81B |
| Q1 2022 | 438 | $4.84B |
| Q4 2021 | 450 | $4.14B |
| Q3 2021 | 430 | $5.14B |
| Q2 2021 | 441 | $5.55B |
| Q1 2021 | 452 | $6.61B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Teva Pharmaceutical Industries Ltd; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −3,564−100.0% | Sold out |
| Godsey & Gibb Associates | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,900−100.0% | Sold out |
| LM Advisors LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −707−100.0% | Sold out |
| Frazier Financial Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Able Wealth Management LLC | 0 | $0 | 0.00% | −344−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Arlington Trust Co LLC | 0 | $0 | 0.00% | −214−100.0% | Sold out |
| JJJ Advisors Inc. | 0 | $0 | 0.00% | −118−100.0% | Sold out |
| Scarborough Advisors, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| SOA Wealth Advisors, LLC. | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −5,442−100.0% | Sold out |
| Greenlight Capital Inc | – | – | – | – | Not filed |
| DFPG Investments, LLC | – | – | – | – | Not filed |
| Desjardins Global Asset Management Inc. | – | – | – | – | Not filed |
| Bartlett & Co. LLC | – | – | – | – | Not filed |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |